Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review
暂无分享,去创建一个
[1] Madhukar Pai,et al. Tuberculosis , 2019, The Lancet.
[2] Jing Wang,et al. Metformin prescription and aortic aneurysm: systematic review and meta-analysis , 2019, Heart.
[3] S. Swaminathan,et al. Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial , 2019, BMJ Open.
[4] M. Netea,et al. Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects , 2019, The Journal of infectious diseases.
[5] M. Fralick,et al. Association of Concussion With the Risk of Suicide: A Systematic Review and Meta-analysis , 2019, JAMA neurology.
[6] Amit Singhal,et al. Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins , 2018, European Respiratory Journal.
[7] Jann-Yuan Wang,et al. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria , 2018, PloS one.
[8] C. Tseng. Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients , 2018, Journal of clinical medicine.
[9] I. Chong,et al. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes , 2018, Respirology.
[10] P. Malhotra,et al. Is metformin poised for a second career as an antimicrobial? , 2018, Diabetes/metabolism research and reviews.
[11] S. Han,et al. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus , 2018, The Korean journal of internal medicine.
[12] Jonathan H. Chung,et al. IMPROVEMENT IN LARGE DENSITY HDL PARTICLE NUMBER BY NMR IS ASSOCIATED WITH IMPROVEMENT IN VASCULAR INFLAMMATION BY 18-FDG PET/CT AT ONE-YEAR IN PSORIASIS , 2018 .
[13] P. Karakousis,et al. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Y. Chan,et al. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment , 2017, Chest.
[15] Metformin for Prediabetes , 2017, JAMA.
[16] P. Senapati,et al. Protective Effect of Metformin Against Tuberculosis in Diabetic Patients , 2016 .
[17] H. Burr,et al. Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603 838 individuals , 2015, The Lancet.
[18] R. Vashisht,et al. Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis , 2015, Journal of Translational Medicine.
[19] G. Kaplan,et al. Metformin as adjunct antituberculosis therapy , 2014, Science Translational Medicine.
[20] A. Earnest,et al. Latent Tuberculosis in Patients with Diabetes Mellitus: Prevalence, Progression and Public Health Implications , 2014, Experimental and Clinical Endocrinology & Diabetes (Barth).
[21] A. Harries,et al. The impact of diabetes on tuberculosis treatment outcomes: A systematic review , 2011, BMC medicine.
[22] P. Escalante. In the clinic. Tuberculosis. , 2009, Annals of internal medicine.
[23] Christine Laine,et al. In the Clinic , 2007, Annals of Internal Medicine.
[24] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[25] S. Schatzki. The clinic. , 1994, AJR. American journal of roentgenology.